Anosmia, Dysgeusia and Associated Factors in Covid-19 Patients: A Cross Sectional Analysis of Different Cohorts Report

Objective:Since the initial appearance of coronavirus disease in 2019 COVID-19), the world has progressed from understanding a couple of symptoms and risk factors to a large rundown of COVID-19 indicators that may also be used for screening and risk stratification. These breakthroughs eventually provided a way into the later development of the potentially lifesaving COVID-19 vaccines. While the prevalence characteristics of pre-symptomatic COVID-19 are easily notable, most critical elements/details of asymptomatic COVID-19,including anosmia and dysgeusia, are scarce and limited in the public domain. Methods: A cross-sectional analysis was performed from June 27 to April 1, 2023, in Riyadh, Saudi Arabia. Two groups, namely Group A and Group B, were studied. Group A included COVID-19 patients hospitalized at any ministery of health hospital in Riyadh, Saudi Arabia, while Group B involved COVID-19 home-quarantined subjects diagnosed in any ministry of health screening centers or any private center approved by the ministry of health in Riyadh.